Synergic Interaction of Rifaximin and Mutaflor (Escherichia coli Nissle 1917) in the Treatment of Acetic Acid-Induced Colitis in Rats
Background. Inflammatory bowel disease results from the dysregulation of immune response to environmental and microbial agents in genetically susceptible individuals. The aim of the present study was to examine the effect of rifaximin and/or Mutaflor (Escherichia coli Nissle 1917, EcN) administratio...
Saved in:
Main Authors: | Artur Dembiński, Zygmunt Warzecha, Piotr Ceranowicz, Marcin Dembiński, Jakub Cieszkowski, Tomasz Gosiewski, Małgorzata Bulanda, Beata Kuśnierz-Cabala, Krystyna Gałązka, Peter Christopher Konturek |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2016/3126280 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Administration of a Next-Generation Probiotic Escherichia coli Nissle 1917-GLP-1 Alleviates Diabetes in Mice With Type 1 and Type 2 Diabetes
by: Jie Luo, et al.
Published: (2025-01-01) -
The use of Positive Psychotherapy tools and concepts in the coming out process of a non-heteronormative (LGBTA) client: A case report
by: Krzysztof Dembinski
Published: (2025-01-01) -
Effect of Endotoxemia in Suckling Rats on Pancreatic Integrity and Exocrine Function in Adults: A Review Report
by: Jolanta Jaworek, et al.
Published: (2018-01-01) -
Efficacy of rifaximin in the treatment of chronic relapsing diverticulitis
by: S. I. Achkasov, et al.
Published: (2012-04-01) -
Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients
by: Agnieszka Żyłka, et al.
Published: (2018-01-01)